Related content

Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

By Castner Stacy   Goldman-Rakic Patricia   Williams Graham  

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 111-125

Springer Publishing Company

Access to resources Recommend Favorite

Sexual dysfunction in male schizophrenia: influence of antipsychotic drugs, prolactin and polymorphisms of the dopamine D2 receptor genes

By Zhang Xiang Rong   Zhang Zhi Jun   Zhu Rong Xin   Yuan Yong Gui   Jenkins Trisha A   Reynolds Gavin P  

Pharmacogenomics, Vol. 12, Iss. 8, 2011-08 ,pp. : 1127-1136

Future Medicine

Access to resources Recommend Favorite

Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development

By  

Current Drug Targets, Vol. 13, Iss. 1, 2012-01 ,pp. : 72-79

Bentham Science Publishers

Access to resources Recommend Favorite

Investigational drugs for schizophrenia targeting the dopamine receptor: Phase II trials

By Rao Naren P   Remington Gary  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 7, 2013-11 ,pp. : 881-894

Informa Healthcare

Access to resources Recommend Favorite

Schizophrenia and L-745, 870, a novel dopamine D4 receptor antagonist

By Bristow L.J.   Kramer M.S.   Kulagowski J.   Patel S.   Ragan C.I.   Seabrook G.R.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 6, 1997-06 ,pp. : 186-188

Elsevier

Access to resources Recommend Favorite